Your brain is already writing your future. Most people never read the draft

Richard Moore
2 hours ago
22 min read

Somewhere inside your skull, right now, roughly 86 billion neurones are firing, rewiring, and quietly deciding what kind of 80-year-old you're going to be. You can't feel it happening.

There's no notification, no warning light. And that's precisely the problem.

Most of us treat our brains the way we treat the boiler in the loft: we assume it'll keep running until the day it doesn't, and then we panic. But the science tells a more hopeful story than that. Roughly 45% of dementia cases are linked to factors we can actually influence, things we eat, how we sleep, who we talk to, what's hiding in our walls (Livingston et al., 2024). That doesn't mean nearly half of all cases can be switched off like a light. It means a meaningful share of Alzheimer's disease, vascular dementia, and other forms of cognitive decline can genuinely be delayed, reduced, or in some cases avoided.

What follows is a tour through what your brain actually is, what wears it down, and what builds it up. Not everything below carries the same weight of evidence, and we'll be upfront about that as we go, because a blog that treats a 30-year randomised trial and a single early-stage theory with the same confident tone isn't actually being honest with you. Your brain isn't a finished manuscript. It's still being drafted, every single day, and you're the one holding the pen.

The three-pound furnace running on whatever you hand it

Your brain makes up about 2% of your body weight, yet it burns through roughly 20% of your entire body's energy supply (Herculano-Houzel, 2011). Pound for pound, it is by far the hungriest organ you own. Every thought, every memory you retrieve, that's neurones firing electrical signals across tiny gaps called synapses, using chemical messengers to pass the message on like a relay race that never stops.

It helps to know a few of the specific characters in this story, because they come up again and again later on. The hippocampus is the brain's running index, the part that catalogues new memories as they're written and lets you flip back to find old ones; it's also one of the first areas damaged in Alzheimer's, which is why memory loss is so often the first thing anyone notices. The frontal lobe is the editor's desk, handling planning, judgement, and self-control, the part of you weighing up whether to have the second glass of wine or finish the report first. And carrying meaning between every paragraph of this internal manuscript is a constant traffic of chemical messengers, neurotransmitters like acetylcholine and dopamine, alongside hormones such as cortisol, each one doing a different job in the sentence. You'll meet several of them properly as we go, because most of what damages or protects the brain works by interfering with, or supporting, this internal messaging system.

What makes the brain remarkable isn't just that it runs on this much fuel. It's that it never stops rebuilding itself. This capacity, neuroplasticity, means your brain is constantly strengthening some connections and pruning others based on what you do, eat, think, and experience. It isn't a finished sculpture. It's wet clay, your whole life.

Wet clay can be shaped well or shaped badly, and most of us are shaping it on autopilot. We assume forgetting where we left the car keys at 70 is simply what happens. Often, it's the accumulated result of thousands of small decisions, many of which are genuinely reversible.

Same birthday, two completely different brains

Picture two people born in the same hospital on the same day. By 80, their brains can look like they belong to different species.

In the landmark Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability, known by the more memorable acronym FINGER, researchers tested this directly rather than guessing. More than 1,200 older adults at risk of cognitive decline were split into two groups: one given general health advice, the other a structured programme of brain-healthy diet, exercise, cognitive training, and vascular risk management. After two years, in a properly randomised trial, the structured group showed 25% greater overall improvement in cognitive performance than the control group, including an 83% greater improvement in executive function and a 150% greater improvement in processing speed compared with control (Ngandu et al., 2015). Not a slower decline. An improvement, in older adults, from lifestyle changes alone.

The 2024 Lancet Commission on dementia prevention lists 14 modifiable risk factors across the lifespan, among them high blood pressure, hearing loss, smoking, physical inactivity, diabetes, excessive alcohol, social isolation, air pollution, and untreated vision loss (Livingston et al., 2024). Addressing enough of them, the Commission estimates, could meaningfully reduce risk across roughly 45% of dementia cases worldwide. Not a guarantee for any one person, but a genuine, evidence-backed opportunity.

It's worth being equally honest about the other side of that figure. Age, family history, and certain genes you're simply born with still account for a substantial share of dementia risk, and no diet, supplement, or amount of willpower changes that part of the equation. This piece is deliberately about the slice you can influence, not a claim that the rest doesn't exist.

This is the optimal snapshot versus the neglected snapshot: one 80-year-old still doing the crossword unaided, another asking the same question for the third time in an hour. The difference very often isn't luck. It's decades of small, repeatable choices. Let's go through them.

What you put on your fork ends up in your frontal lobe

The MIND diet, short for Mediterranean-DASH Intervention for Neurodegenerative Delay, blends the Mediterranean diet with the DASH diet (Dietary Approaches to Stop Hypertension), built around leafy greens, berries, nuts, olive oil, and fish, and was developed because certain food patterns kept showing up alongside slower cognitive ageing in long-term observational studies (Morris et al., 2015). But when researchers finally tested it in a three-year randomised controlled trial, something humbling happened: both the MIND diet group and a control group given general healthy-eating advice improved by similar amounts (Barnes et al., 2023). The control group, it turned out, was already eating reasonably well, which narrowed the gap more than anyone expected going in. Almost any move away from a poor-quality diet towards a nutrient-dense one appears to help, and for most people the bigger risk isn't picking the wrong healthy diet, it's what ends up filling the gap instead.

In a cohort study following more than 10,000 adults in Brazil for eight years, those eating the most ultra-processed food had a 28% faster rate of overall cognitive decline and a 25% faster decline in executive function than those eating the least (Gonçalves et al., 2023). Think of it as sending your brain a constant stream of low-quality, badly addressed mail, high in additives, low in the fibre and micronutrients neurones need for maintenance, and often crowding out the foods that would otherwise be doing the protecting.

Two specific foods deserve naming, because the data behind them is unusually solid for nutrition science. Researchers at Rush University followed 960 older adults for nearly five years, tracking their leafy green intake. Those eating roughly 1.3 servings a day showed cognitive decline slow enough that the difference, compared with people eating almost none, was equivalent to being 11 years younger (Morris et al., 2018), tracked specifically to the folate, vitamin K, and lutein these vegetables are rich in. And in the long-running Nurses' Health Study, women eating the most blueberries and strawberries had memory decline delayed by up to two and a half years, an effect linked to anthocyanins, the pigments that give berries their colour and appear to dampen inflammation directly in the brain (Devore et al., 2012).

The habits quietly working against you

This isn't about guilt. It's about choices made with the actual numbers in front of you, because right now most people are making them blind.

Start with alcohol, since the result here genuinely surprised the researchers who produced it. A 30-year study of 550 adults in the Whitehall II cohort found that people drinking what was then considered a perfectly moderate amount, 14 to 21 units a week, had over three times the odds of hippocampal atrophy compared with people who didn't drink at all, with no evidence that light drinking offered any protective effect (Topiwala et al., 2017). The hippocampus keeps a running tally regardless of how the drinking feels at the time.

Smoking tells an equally clear story, with a genuinely hopeful twist. A meta-analysis of 37 cohort studies and nearly a million people found current smokers had a 30% higher risk of all-cause dementia and a 40% higher risk of Alzheimer's specifically, climbing a further 34% for every additional 20 cigarettes a day (Zhong et al., 2015). The hopeful part: former smokers in that same analysis showed no increased risk at all compared with people who'd never smoked. Risk appears to fall back toward baseline once the smoke stops, not instantly, but it does fall.

Then there's the one almost nobody checks: blood sugar. A five-year study of over 2,000 adults, using more than 35,000 individual glucose readings, found dementia risk climbing even in people without diabetes, with no safe lower threshold inside the "normal" range; someone averaging 115 milligrams per decilitre (mg/dL) carried an 18% higher risk than someone averaging 100 mg/dL (Crane et al., 2013). Some researchers have started calling the underlying mechanism, chronically elevated glucose damaging the brain's own insulin signalling, "type 3 diabetes," half-jokingly, but the data behind it isn't a joke.

And finally, the habit that doesn't feel like a habit because it's an absence rather than an action. A seven-year study of over 400 older adults wearing objective activity trackers found that more sitting time meant faster hippocampal shrinkage and worse memory, regardless of how much structured exercise people also did, an effect strongest in those carrying the APOE4 gene, a variant of the apolipoprotein E gene that's the single strongest known genetic risk factor for late-onset Alzheimer's (Gogniat et al., 2025). A daily gym session, it turns out, doesn't cancel out ten hours at a desk. As far as your brain is concerned, movement and stillness appear to be two separate conversations.

The supplement aisle doesn't know your genes (we can find out)

Walk into any pharmacy and you'll find a wall of fish oil capsules promising sharper memory. The science is more personal than the label lets on. Omega-3 fatty acids genuinely matter for brain structure, but large supplementation trials have produced mixed results, and one striking recent finding is that the benefit appears to depend heavily on that same APOE4 gene mentioned earlier. Carriers seem to respond to omega-3 supplementation quite differently from non-carriers, sometimes with less benefit, sometimes none at all (Norwitz et al., 2021). Blanket advice to "just take fish oil" doesn't account for the fact that your response may depend partly on your particular biology.

Vitamin D tells a similar story with sharper numbers. In a study of 1,658 older adults followed for 5.6 years, those severely deficient had a 125% higher risk of developing dementia and a 122% higher risk of Alzheimer's specifically, with even moderate deficiency carrying a 53% higher dementia risk (Littlejohns et al., 2014). Most people in the UK simply don't know where their own levels sit. That's the entire logic behind nutrigenomic and biomarker testing: rather than guessing what your brain needs, you ask it directly.

Move your legs, grow your memory

Researchers took 120 older adults already showing the natural age-related shrinkage in the hippocampus, and put half through a year of moderate aerobic walking, the other half through gentle stretching. The walking group's hippocampus didn't just stop shrinking, it grew by about 2%, reversing roughly one to two years of age-related volume loss (Erickson et al., 2011). It's one of the most striking results in this field, and worth treating as exactly that: one well-designed trial, since later attempts to reproduce that specific volume increase have shown more mixed results, even as the wider link between aerobic fitness and hippocampal health continues to hold up. Aerobic exercise raises a protein called brain-derived neurotrophic factor (BDNF), which behaves almost like fertiliser for new connections in the hippocampus. You're not just burning calories on a walk, you're prompting your brain to build new infrastructure, though as the previous section showed, that's most powerful added on top of less sitting overall, not as a single daily licence to stay still the rest of the time.

The cleaning crew that only clocks in while you're asleep

Here's something almost nobody is taught at school: your brain has its own internal plumbing system, and growing evidence suggests it works hardest while you're in deep sleep. It's called the glymphatic system, and it flushes fluid through the channels wrapping your brain's blood vessels, washing away waste including amyloid-beta, the protein implicated in Alzheimer's. The most dramatic number behind this theory, that the space between brain cells expands by around 60% during sleep, comes from mice rather than people (Xie et al., 2013); we don't yet have that level of precision in living human brains, though the broader pattern of improved waste clearance during sleep does appear to hold up in human research too. Researchers now describe failure of this system as a possible common pathway towards several forms of dementia, not just Alzheimer's, but Parkinson's too (Nedergaard & Goldman, 2020).

Picture storm drains that only fully open once the city goes quiet for the night. Skip deep sleep often enough, and on current evidence, the rubbish simply doesn't get collected as efficiently.

The emergency contractor you really don't want living in your house

Cortisol gets unfairly demonised. In a genuine crisis, it's brilliant. The problem is what happens when the emergency never officially ends. The hippocampus is riddled with cortisol receptors, more than almost any other brain region, making it exquisitely sensitive to stress hormone levels over months and years (McEwen, 2007). Chronic, never-switches-off stress keeps cortisol elevated long enough to interfere with the birth of new neuronse and physically shrink the branching connections between them.

It's a bit like hiring a contractor for a five-minute emergency repair and never asking him to leave. Superb in a crisis. Left to live in the house indefinitely, he starts knocking through walls that were load-bearing.

What's in your walls, your water, and your bones

In a nationally representative study of over 27,000 American adults followed for a decade, those with higher long-term exposure to fine particulate air pollution had a meaningfully higher rate of developing dementia, strongest for pollution sourced from agriculture and wildfires (Zhang et al., 2023). These particles are small enough to slip past the lungs' defences and reach brain tissue directly.

Lead is the toxin most of us assume belongs to the past, and in some ways it does, leaded petrol disappeared from Britain decades ago, but the metal itself doesn't disappear once it's in the body. It settles into bone and can stay there for decades, slowly re-entering the bloodstream as bone naturally remodels with age. A 2026 analysis of nationally representative US health data, following participants for up to 30 years, found that people with the highest long-term bone lead levels had nearly three times the risk of Alzheimer's disease and more than twice the risk of all-cause dementia compared with those at the lowest levels, while current blood lead levels on their own showed no significant link (Wang et al., 2026). It isn't what's in your blood today that seems to matter most, it's what your skeleton has been quietly storing since childhood. Older housing stock, common across much of the UK, can still carry lead in ageing paint and pipework, which is worth knowing about for the building you actually live in.

Damp buildings carry a quieter, less settled risk of their own. Certain mould species release mycotoxins small enough to cross the blood-brain barrier, and laboratory research links several of these compounds to neuroinflammation and impaired memory (Hoxha et al., 2025). The evidence here is mechanistic and still emerging, not the large human trials behind exercise or hearing loss, so we'd call it a plausible risk worth checking for rather than a settled one.

And then there's a toxin that didn't exist a century ago and now appears to be inside all of our brains. Researchers analysing donated human brain tissue found measurable concentrations of microplastics and nanoplastics in every sample tested, with brain tissue containing markedly higher concentrations than liver or kidney from the same individuals, and concentrations in samples from 2024 noticeably higher than those from 2016, just eight years earlier (Nihart et al., 2025). Brains from people with a documented dementia diagnosis carried substantially more of this material than brains without, though the researchers themselves are careful to call this an association rather than proof of cause and effect. The likely sources are mundane: bottled water, synthetic fabrics, food packaging, and dust shed from furniture and carpets. Nobody is suggesting you can plastic-proof your home, but reducing the obvious sources is a reasonable, low-cost precaution while the science catches up with what's already accumulating. It's exactly the kind of thing toxin screening exists to help make sense of, without overstating what we currently know.

The hit you don't feel until decades later

This one rarely makes it into a brain health article. A study examining the brains of 631 former American football players, using real helmet-impact data spanning 30 years, found every additional year playing the sport raised the odds of a diagnosis of chronic traumatic encephalopathy (CTE) at autopsy by 15%, and that the strongest predictor wasn't diagnosed concussions, but the cumulative force of total head impacts, including hits nobody noticed at the time (Daneshvar et al., 2023). CTE causes tau protein, the same tangle seen in Alzheimer's, to build up over years, eventually producing memory loss and dementia long after the playing days end.

You don't need to have played professional contact sport for the principle to apply. Amateur rugby, heading footballs repeatedly, cycling without a helmet, the injury isn't the bruise you can see. It's the one quietly forming where you can't.

The pill bottle that's quietly borrowing from your memory

Nobody warns you about this one at the pharmacy counter. A wide group of common medications, including certain antidepressants, antihistamines, and bladder medications, work by blocking acetylcholine, one of the most important chemical messengers for memory. In a study tracking nearly 285,000 adults aged 55 and over, those exposed to the highest cumulative doses of anticholinergic drugs over the preceding decade had significantly higher rates of developing dementia (Coupland et al., 2019). This isn't a reason to panic and stop any medication, some are essential and stopping abruptly can be dangerous, but it's a strong reason to have everything in your cabinet properly reviewed rather than simply renewed on repeat.

Lonely brains age faster, even when nothing else is wrong

Loneliness doesn't show up on a blood test, and maybe it should. In the largest analysis ever conducted on this question, pooling data from over 600,000 people across 21 studies, feeling lonely raised dementia risk by 31%, with Alzheimer's risk up 14% and vascular dementia up 17%, holding true even after accounting for depression and how many social contacts someone actually had (Luchetti et al., 2024). That 31% sits roughly in the same range as the smoking and inactivity figures cited elsewhere in this piece, though comparing effect sizes across entirely different studies is always a rough guide rather than an exact equivalence. Connection appears to function almost like a nutrient in its own right, switching off the same chronic inflammation and stress-hormone cascade described earlier.

Turn up the volume, turn down the risk

Hearing loss is one of the largest single modifiable risk factors for dementia identified anywhere in the research, an estimated 8% of all dementia risk globally (Livingston et al., 2024), likely because a brain straining to decode muffled speech has less bandwidth left for memory, while social withdrawal compounds the loneliness risk above. In the Aging and Cognitive Health Evaluation in Elders trial, known as ACHIEVE, the first randomised controlled trial to test this directly, hearing aids used for three years cut cognitive decline almost in half among older adults already at higher risk (Lin et al., 2023).

This connects to cognitive reserve: years of education, stimulating work, and rich engagement build a scaffolding of extra neural pathways that let the brain absorb damage without symptoms showing (Stern, 2009). One of the clearest examples involves something most of us think of as a cultural quirk rather than a medical advantage: in a study of 648 dementia patients in India, bilingual patients developed first symptoms 4.5 years later than monolingual patients, a gap that held even among people who'd never learned to read in either language (Alladi et al., 2013). Not every study agrees on the size of this effect, and a handful have found none at all, but the pattern has turned up often enough across different countries to take seriously. Picture two gearboxes: one shifts constantly between languages and stays mechanically limber from the repetition, the other, used only one way for decades, seizes that little bit faster when it eventually has to compensate.

The habit Finland has apparently been right about all along

In the Kuopio Ischaemic Heart Disease study, researchers tracked 2,315 healthy Finnish men for an average of 20 years. Men sauna-bathing four to seven times a week had a 66% lower risk of developing any dementia and a 65% lower risk of Alzheimer's specifically, compared with men bathing just once a week, holding after accounting for blood pressure, smoking, and alcohol use (Laukkanen et al., 2017). Worth flagging honestly: this is a single cohort, in a country where sauna use is woven into daily life from infancy, and it hasn't been replicated in a population without that lifelong habit, so we'd treat it as a genuinely interesting lead rather than settled advice for taking up sauna bathing for the first time at 60. Nobody has fully nailed the mechanism, but the leading theories point to improved cardiovascular function and a brief surge of heat shock proteins, the cellular equivalent of a fire drill that leaves a building's safety systems sharper afterwards. Not every protective habit involves effort. Sometimes it's sitting still in a warm room, several times a week, for twenty years.

What's coming next will change everything we just told you

For most of medical history, confirming Alzheimer's pathology required an invasive lumbar puncture or an expensive positron emission tomography (PET) scan. A new generation of blood tests measuring plasma p-tau217 can now detect Alzheimer's-related brain changes with accuracy approaching those far more invasive methods, validated across thousands of participants in cohorts spanning the US, Europe, Australia, and Canada (Ashton et al., 2024). Biological risk can, in principle, be measured years before any symptom appears.

Glucagon-like peptide-1 (GLP-1) medications, developed for diabetes and weight management, are now showing signals of brain protection too. In a real-world study of over 60,000 adults with type 2 diabetes and obesity, those started on semaglutide or tirzepatide had a 37% lower risk of developing dementia than those on other antidiabetic medications, alongside reduced stroke and mortality (Lin et al., 2025). A word of caution here: this is observational data drawn from people already prescribed these drugs for diabetes, not evidence that taking one specifically to protect your brain is a good idea. It's a genuinely fascinating signal worth watching, dedicated Alzheimer's trials are due to report soon, but not yet a recommendation to act on.

And then there's your gut. A growing body of research on the gut-brain axis suggests disruption to the gut's microbial community drives the kind of chronic inflammation that fuels Alzheimer's pathology over time (Pasupalak et al., 2024). Since your microbiome is shaped largely by what you eat, the food choices earlier in this piece may be doing double duty, feeding you, and quietly negotiating with your immune system on your brain's behalf.

Your brain doesn't get a second draft

Here's the uncomfortable truth and the genuinely good news, in the same sentence: nobody else is coming to do this for you, but most of what shapes your brain's future is substantially within your influence.

The honest difference between the person doing the crossword unaided at 85 and the person who can't recall their own address isn't usually one dramatic event. It's thousands of ordinary decisions about food, drink, sleep, movement, medication, connection, and exposure, compounding quietly over decades. The frustrating part is that most of us make those decisions half blind, with no real idea whether our vitamin D is where it should be, whether our genes mean a popular supplement is doing nothing for us, or whether something in our daily environment is quietly working against us.

That's really what our MOT programme at You Nutrition Clinic exists to answer: not a generic checklist, but an honest, personal picture of what your own brain actually needs. We look at your blood markers, your genetics, your gut, your environment, and early signals that can flag your risk for conditions like Alzheimer's disease and vascular dementia, often years before anything would show up in a GP's office, then sit down with you and turn what we find into a plan that's actually yours.

Your brain is writing its future right now, with or without your input. The only real question is whether you want to read the draft while there's still time to edit it. If you do, we'd love to help you start.

If you would like support interpreting your own nutritional and biochemical picture in the context of ALS, you can book a consultation with You Nutrition Clinic by contacting admin@younutritionclinic.com or go directly to www.younutritionclinic.com

🧩 Connect with us

For research updates, practical tips, and ongoing inspiration, follow us on Instagram:

👉 @nutritionandthebrain

👉 @younutritionkids

Stay curious. Stay hopeful. Support your brain. 🧠

Disclaimer: This article is for informational and educational purposes only and does not constitute medical advice. Always consult with a qualified, registered medical doctor (MD) for diagnosis and treatment decisions.

References

Alladi, S., Bak, T. H., Duggirala, V., Surampudi, B., Shailaja, M., Shukla, A. K., Chaudhuri, J. R., & Kaul, S. (2013). Bilingualism delays age at onset of dementia, independent of education and immigration status. Neurology, 81(22), 1938–1944. https://doi.org/10.1212/01.wnl.0000436620.33155.a4

Ashton, N. J., Brum, W. S., Di Molfetta, G., Benedet, A. L., Arslan, B., Jonaitis, E., Langhough, R. E., Cody, K., Wilson, R., Carlsson, C. M., Vanmechelen, E., Montoliu-Gaya, L., Lantero-Rodriguez, J., Rahmouni, N., Pascoal, T. A., Stevenson, J., Servaes, S., Therriault, J., & Hansson, O. (2024). Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer disease pathology. JAMA Neurology, 81(3), 255–263. https://doi.org/10.1001/jamaneurol.2023.5319

Barnes, L. L., Dhana, K., Liu, X., Carey, V. J., Ventrelle, J., Johnson, K., Hollings, C. S., Bishop, L., Laranjo, N., Stubbs, B. J., Reilly, X., Agarwal, P., Zhang, S., Grodstein, F., Tangney, C. C., Holland, T. M., Aggarwal, N. T., Arfanakis, K., Morris, M. C., & Sacks, F. M. (2023). Trial of the MIND diet for prevention of cognitive decline in older persons. New England Journal of Medicine, 389(7), 602–611. https://doi.org/10.1056/NEJMoa2302368

Coupland, C. A. C., Hill, T., Dening, T., Morriss, R., Moore, M., & Hippisley-Cox, J. (2019). Anticholinergic drug exposure and the risk of dementia: A nested case-control study. JAMA Internal Medicine, 179(8), 1084–1093. https://doi.org/10.1001/jamainternmed.2019.0677

Crane, P. K., Walker, R., Hubbard, R. A., Li, G., Nathan, D. M., Zheng, H., Haneuse, S., Craft, S., Montine, T. J., Kahn, S. E., McCormick, W., McCurry, S. M., Bowen, J. D., & Larson, E. B. (2013). Glucose levels and risk of dementia. New England Journal of Medicine, 369(6), 540–548. https://doi.org/10.1056/NEJMoa1215740

Daneshvar, D. H., Nair, E. S., Baucom, Z. H., Rasch, A., Abdolmohammadi, B., Uretsky, M., Saltiel, N., Shah, A., Jarnagin, J., Baugh, C. M., Martin, B. M., Palmisano, J. N., Cherry, J. D., Alvarez, V. E., Huber, B. R., Weuve, J., Nowinski, C. J., Cantu, R. C., Zafonte, R. D., ... Mez, J. (2023). Leveraging football accelerometer data to quantify associations between repetitive head impacts and chronic traumatic encephalopathy in males. Nature Communications, 14(1), 3470. https://doi.org/10.1038/s41467-023-39183-0

Devore, E. E., Kang, J. H., Breteler, M. M. B., & Grodstein, F. (2012). Dietary intakes of berries and flavonoids in relation to cognitive decline. Annals of Neurology, 72(1), 135–143. https://doi.org/10.1002/ana.23594

Erickson, K. I., Voss, M. W., Prakash, R. S., Basak, C., Szabo, A., Chaddock, L., Kim, J. S., Heo, S., Alves, H., White, S. M., Wojcicki, T. R., Mailey, E., Vieira, V. J., Martin, S. A., Pence, B. D., Woods, J. A., McAuley, E., & Kramer, A. F. (2011). Exercise training increases size of hippocampus and improves memory. Proceedings of the National Academy of Sciences, 108(7), 3017–3022. https://doi.org/10.1073/pnas.1015950108

Gogniat, M. A., Khan, O. A., Li, J., Park, C., Robb, W. H., Zhang, P., Sun, Y., Moore, E. E., Houston, M. L., Pechman, K. R., Shashikumar, N., Davis, L. T., Liu, D., Landman, B. A., Cole, K. R., Bolton, C. J., Gifford, K. A., Hohman, T. J., Full, K., & Jefferson, A. L. (2025). Increased sedentary behavior is associated with neurodegeneration and worse cognition in older adults over a 7-year period despite high levels of physical activity. Alzheimer's & Dementia, 21(5), e70157. https://doi.org/10.1002/alz.70157

Gonçalves, N. G., Vidal Ferreira, N., Khandpur, N., Martinez Steele, E., Bertazzi Levy, R., Andrade Lotufo, P., Bensenor, I. M., Caramelli, P., Alvim de Matos, S. M., & Suemoto, C. K. (2023). Association between consumption of ultraprocessed foods and cognitive decline. JAMA Neurology, 80(2), 142–150. https://doi.org/10.1001/jamaneurol.2022.4397

Herculano-Houzel, S. (2011). Scaling of brain metabolism with a fixed energy budget per neuron: Implications for neuronal activity, plasticity and evolution. PLOS ONE, 6(3), e17514. https://doi.org/10.1371/journal.pone.0017514

Hoxha, M., Abbasciano, M., Avantaggiato, G., Zappacosta, B., & Tricarico, D. (2025). Mycotoxins and neuropsychiatric symptoms: Possible role in special refugee populations. Frontiers in Pharmacology, 16, Article 1524152. https://doi.org/10.3389/fphar.2025.1524152

Laukkanen, T., Kunutsor, S., Kauhanen, J., & Laukkanen, J. A. (2017). Sauna bathing is inversely associated with dementia and Alzheimer's disease in middle-aged Finnish men. Age and Ageing, 46(2), 245–249. https://doi.org/10.1093/ageing/afw212

Lin, F. R., Pike, J. R., Albert, M. S., Arnold, M., Burgard, S., Chisolm, T., Couper, D., Deal, J. A., Goman, A. M., Glynn, N. W., Gmelin, T., Gravens-Mueller, L., Hayden, K. M., Huang, A. R., Knopman, D., Mitchell, C. M., Mosley, T., Pankow, J. S., Reed, N. S., Sanchez, V., Schrack, J. A., Windham, B. G., & Coresh, J. (2023). Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): A multicentre, randomised controlled trial. The Lancet, 402(10404), 786–797. https://doi.org/10.1016/S0140-6736(23)01406-X

Lin, H.-T., Tsai, Y.-F., Liao, P.-L., & Wei, J. C.-C. (2025). Neurodegeneration and stroke after semaglutide and tirzepatide in patients with diabetes and obesity. JAMA Network Open, 8(7), e2521016. https://doi.org/10.1001/jamanetworkopen.2025.21016

Littlejohns, T. J., Henley, W. E., Lang, I. A., Annweiler, C., Beauchet, O., Chaves, P. H. M., Fried, L., Kestenbaum, B. R., Kuller, L. H., Langa, K. M., Lopez, O. L., Kos, K., Soni, M., & Llewellyn, D. J. (2014). Vitamin D and the risk of dementia and Alzheimer disease. Neurology, 83(10), 920–928. https://doi.org/10.1212/WNL.0000000000000755

Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., Fox, N. C., Ferri, C. P., Gitlin, L. N., Howard, R., Kales, H. C., Kivimäki, M., Larson, E. B., Nakasujja, N., Rockwood, K., Samus, Q., Shirinyan, D., Singh-Manoux, A., Schneider, L., Walsh, S., Yao, Y., Sommerlad, A., & Mukadam, N. (2024). Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The Lancet, 404(10452), 572–628. https://doi.org/10.1016/S0140-6736(24)01296-0

Luchetti, M., Aschwanden, D., Sesker, A. A., Zhu, X., O'Súilleabháin, P. S., Stephan, Y., Terracciano, A., & Sutin, A. R. (2024). A meta-analysis of loneliness and risk of dementia using longitudinal data from >600,000 individuals. Nature Mental Health, 2(11), 1350–1361. https://doi.org/10.1038/s44220-024-00328-9

McEwen, B. S. (2007). Physiology and neurobiology of stress and adaptation: Central role of the brain. Physiological Reviews, 87(3), 873–904. https://doi.org/10.1152/physrev.00041.2006

Morris, M. C., Tangney, C. C., Wang, Y., Sacks, F. M., Bennett, D. A., & Aggarwal, N. T. (2015). MIND diet associated with reduced incidence of Alzheimer's disease. Alzheimer's & Dementia, 11(9), 1007–1014. https://doi.org/10.1016/j.jalz.2014.11.009

Morris, M. C., Wang, Y., Barnes, L. L., Bennett, D. A., Dawson-Hughes, B., & Booth, S. L. (2018). Nutrients and bioactives in green leafy vegetables and cognitive decline: Prospective study. Neurology, 90(3), e214–e222. https://doi.org/10.1212/WNL.0000000000004815

Nedergaard, M., & Goldman, S. A. (2020). Glymphatic failure as a final common pathway to dementia. Science, 370(6512), 50–56. https://doi.org/10.1126/science.abb8739

Ngandu, T., Lehtisalo, J., Solomon, A., Levälahti, E., Ahtiluoto, S., Antikainen, R., Bäckman, L., Hänninen, T., Jula, A., Laatikainen, T., Lindström, J., Mangialasche, F., Paajanen, T., Pajala, S., Peltonen, M., Rauramaa, R., Stigsdotter-Neely, A., Strandberg, T., Tuomilehto, J., Soininen, H., & Kivipelto, M. (2015). A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomised controlled trial. The Lancet, 385(9984), 2255–2263. https://doi.org/10.1016/S0140-6736(15)60461-5

Nihart, A. J., Garcia, M. A., El Hayek, E., Liu, R., Olewine, M., Kingston, J. D., Castillo, E. F., Gullapalli, R. R., Howard, T., Bleske, B., Scott, J., Gonzalez-Estrella, J., Gross, J. M., Spilde, M., Adolphi, N. L., Gallego, D. F., Jarrell, H. S., Dvorscak, G., Zuluaga-Ruiz, M. E., West, A. B., & Campen, M. J. (2025). Bioaccumulation of microplastics in decedent human brains. Nature Medicine, 31(4), 1114–1119. https://doi.org/10.1038/s41591-024-03453-1

Norwitz, N. G., Saif, N., Ariza, I. E., & Isaacson, R. S. (2021). Precision nutrition for Alzheimer's prevention in ApoE4 carriers. Nutrients, 13(4), 1362. https://doi.org/10.3390/nu13041362

Pasupalak, J. K., Rajput, P., & Gupta, G. L. (2024). Gut microbiota and Alzheimer's disease: Exploring natural product intervention and the gut-brain axis for therapeutic strategies. European Journal of Pharmacology, 984, 177022. https://doi.org/10.1016/j.ejphar.2024.177022

Stern, Y. (2009). Cognitive reserve. Neuropsychologia, 47(10), 2015–2028. https://doi.org/10.1016/j.neuropsychologia.2009.03.004

Topiwala, A., Allan, C. L., Valkanova, V., Zsoldos, E., Filippini, N., Sexton, C., Mahmood, A., Fooks, P., Singh-Manoux, A., Mackay, C. E., Kivimäki, M., & Ebmeier, K. P. (2017). Moderate alcohol consumption as risk factor for adverse brain outcomes and cognitive decline: Longitudinal cohort study. BMJ, 357, j2353. https://doi.org/10.1136/bmj.j2353

Wang, X., Bakulski, K. M., Walker, E., Mukherjee, B., Dodge, H., Albin, R. L., Paulson, H. L., & Park, S. K. (2026). Exposure to lead and incidence of Alzheimer's disease and all-cause dementia in the United States. Alzheimer's & Dementia. Advance online publication. https://doi.org/10.1002/alz.71075

Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O'Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., Takano, T., Deane, R., & Nedergaard, M. (2013). Sleep drives metabolite clearance from the adult brain. Science, 342(6156), 373–377. https://doi.org/10.1126/science.1241224

Zhang, B., Weuve, J., Langa, K. M., D'Souza, J., Szpiro, A., Faul, J., Mendes de Leon, C., Gao, J., Kaufman, J. D., Sheppard, L., Lee, J., Kobayashi, L. C., Hirth, R., & Adar, S. D. (2023). Comparison of particulate air pollution from different emission sources and incident dementia in the US. JAMA Internal Medicine, 183(10), 1080–1089. https://doi.org/10.1001/jamainternmed.2023.3300

Zhong, G., Wang, Y., Zhang, Y., Guo, J. J., & Zhao, Y. (2015). Smoking is associated with an increased risk of dementia: A meta-analysis of prospective cohort studies with investigation of potential effect modifiers. PLOS ONE, 10(3), e0118333. https://doi.org/10.1371/journal.pone.0118333